A. Brewster

Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial

Lindsay C Thompson, Harpreet Wasan, Gary Middleton et al. · The Lancet · 2011 · 412 citations · Full text

Geriatric Oncology, Oncology, Geriatrics +10

Multidisciplinary team management is associated with improved outcomes after surgery for esophageal cancer

Michael Stephens, Wyn G. Lewis, A. Brewster et al. · Diseases of the Esophagus · 2006 · 268 citations · Full text

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial

John Bridgewater, S. Pugh, Tom Maishman et al. · The Lancet Oncology · 2020 · 227 citations · Full text

Low-Dose Cyclophosphamide Induces Antitumor T-Cell Responses, which Associate with Survival in Metastatic Colorectal Cancer

Martin Scurr, Tom Pembroke, Anja Bloom et al. · Clinical Cancer Research · 2017 · 159 citations · Full text

The National Lung Matrix Trial of personalized therapy in lung cancer

Gary Middleton, Peter Fletcher, Sanjay Popat et al. · Nature · 2020 · 133 citations · Full text

Oncology, Advanced Lung Disease, Bronchial Neoplasm +7